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Abstract: 
Histone acetyltransferase (HAT) is an enzyme required for chromatin remodeling and transcriptional
 activation. Sarcoendoplasmic 
reticulum Ca
2+ ATPase (SERCA) is an ATP coupled Ca
2+ ion pump involved in metabolic arrest. Both these enzymes are present in 
Plasmodia and have been selected as molecular targets for in silico studies of some new non-resistant antimalarial drugs like 
artemisinin, curcumin and diarylheptanoids along with some other inhibitors reported in literature. Ten top inhibitors have also been 
generated based on common pharmacophore from ZINC database. The HAT enzyme was modeled with the help of the Modeller 
software and the SERCA enzyme pdb file was obtained from the protein data bank. Ligbuilder was used for structure based drug 
designing, which generated a common pharmacophore of the ligands. Molegro was used to perform virtual screening of the hits 
from the pharmacophore based Zinc database search and known inhibitors of the enzymes from the literature survey. Curcumin 
shows good and optimal binding to both HAT and SERCA enzymes; therefore it might be a good inhibitor of these key enzymes in 
Plasmodium. Curcumin is reported to act synergistically with artemisinin which forms covalent adducts with the transmembrane 
proteins (SERCA enzyme) and inactivates them, thus inhibiting the activity of Plasmodium parasite. This combination has already 
been reported to be effective in malaria treatment. Some other diarylheptanoids besides curcumin showed better binding to both the 
enzymes. Therefore, a combination of artemisinin and diarylheptanoids can prove to be better combination for antimalarial therapy. 
Different formulations involving curcumin, artimisinin and diarylheptanoids may result in a more potent antimalarial drug. 
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Background: 
Malaria is fast becoming a serious threat to public health 
throughout the world especially in endemic regions like India 
and Africa. The malarial parasite Plasmodium falciparum is 
responsible for around one million deaths each year. Its life 
cycle involves many morphologically distinct stages, which 
alternate between a vertebrate and an invertebrate host. Like 
other eukaryotes, the malaria parasite DNA
 is organized into 
nucleosomes and the genome encodes components
  of 
chromatin-remodeling complexes. Falciparum species is more 
common in Africa while in India vivax is more common. 
Plasmodium has developed resistance to most of the existing 
drugs e.g. Mefloquin and Chloroquin, as well as the 
combination of drugs. The reason has been attributed to the 
decreased susceptibility of resistance transporters (PfCRT) for 
chloroquin and (PfMDR1) for multidrug resistance [1]. 
Therefore, there is a growing need to develop newer drugs and 
drug combinations to inhibit the growth of protozoa. This 
requires work on new molecular targets in Plasmodium and 
designing inhibitors with good parasiticidal activity and also 
which are cost effective to the underprivileged population of the 
developing world and impose less financial burden on their 
governments. In the present study we have selected two 
enzymes present in Plasmodium as molecular targets viz. 
Histone acetyltransferase and Sarcoendoplasmic reticulum 
ATPase.  
 
Histone acetyltransferases (HAT) are enzymes that acetylate 
conserved  lysine residues at N-terminal tails of core histone 
proteins by transferring an acetyl group from acetyl CoA to 
lysine to form ε-N-acetyl lysine, neutralizing their positive 
charges. Thus presumably the affinity of the histones is reduced 
for the DNA (which is negatively charged), which lead to 
nucleosomes being unfolded and increase access to 
transcriptional factors. Thus, histone acetylation is generally 
linked to transcriptional activation generally associated with 
euchromatin. Lysine acetylation and other post translational 
modifications of histones generate binding sites for specific 
protein-protein interaction domains, such as the acetyl-lysine 
binding  bromodomain  [2]. Its inhibition will lead to 
transcriptional deactivation and therefore the enzyme can be 
used as a novel drug target in Plasmodium. Ion pumping is one 
of the most energetically taxing physiological processes in cells, 
and ion motive ATPases are likely loci to be differentially 
regulated in models of metabolic arrest. We propose that the 
deactivation of sarcoendoplasmic reticulum (SER) calcium-
ATPase(SERCA) would potentially contribute to the overall Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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suppression of metabolism [3]. In case of inhibition of activity 
of these two enzymes the Plasmodium would not be able to 
complete its life cycle. In the present work we have docked 
some latest antimalarials in use like artimisinin and curcumin. 
In addition we have selected ten top inhibitors from ZINC 
database. The synergistic effect of formulations of these herbal 
products is also expected to yield excellent results. 
 
 
Figure 1: Structure of Artemisinin. 
  
Methodology: 
The following software’s were used, MODELLER for modeling 
the Histone acetyltransferase protein, SPDB Viewer for loop 
modeling, LIGBUILDER for structure based drug designing, 
MOLEGRO for docking and  virtual screening. 
 
Protein modeling 
MODELLER software was used for modelling the Histone 
acetyltransferase protein. Doing loop modelling on the 
SPDBViewer so that 88% of the amino acid residues fall within 
the acceptable region of the Ramachandran plot did further 
refinement of the protein structure. 
  
Ligand designing 
LIGBUILDER was used for structure based drug designing on 
the Histone acetyltransferase protein. Ligand was developed by 
both LINK and GROW methods, 200 ligands by GROW and 
around 1000 ligands by LINK techniques were generated along 
with a common parmacophore of the generated ligands. 
Pharmacophore based search was performed on the ZINC 
database and around 78 hits were found. Also some known 
inhibitors of the Histone actyltransferase enzyme were found on 
Literature survey. The known inhibitors are Isothiazolones, 
Garcinol, Quinolones, Anacardic Acid and Curcumin. Other 
diarylheptanoid compounds were also selected. Their 3-D 
coordinates were generated after drawing their 2-D structures 
on CORINA software 
 
Virtual screening 
Virtual screening of the above compounds on the Histone 
acetyltransferase enzyme was performed on the MOLEGRO 
software and the top 10 compounds with the best docking 
energies were obtained. These compounds were also docked on 
Sarcoendoplasmic reticulum Ca (2+) ATPase enzyme protein. 
Sarcoendoplasmic reticulum ATPase enzyme pdb file was 
obtained from the protein data bank. . Curcumin was found to 
have good binding to both HAT and SERCA enzymes. 
Diarylheptanoids have shown better binding to both these 
enzymes therefore suggesting it might be a better inhibitor of 
these key enzymes in Plasmodium. Curcumin was docked with 
SERCA enzyme and the curcumin bound SERCA enzyme was 
saved in the pdb format. This pdb file was docked with the 
different diarylheptanoids and their docking energies (of 
curcumin bound SERCA enzyme) were compared to those 
where diarylheptanoids were docked with the SERCA enzyme 
(without curcumin) as such (see Table 3, supplementary 
material). 
 
Discussion: 
Curcumin (See Table 1 under supplementary material) shows 
good and optimal binding to both Histone acetyltransferase 
(HAT) and Sarcoendoplasmic Reticulum Ca (2+) ATPase 
(SERCA) enzymes, therefore it might be a good inhibitor of 
these key enzymes in Plasmodium. Curcumin is reported to act 
synergistically with artemisinin (Figure 1) which forms 
covalent adduct with the transmembrane proteins 
(Sarcoendoplasmic Reticulum Ca
2+  ATPase enzyme) and 
inactivates them, thus inhibiting the activity of Plasmodium 
parasite. This combination has already been reported to be 
effective in malaria treatment
 [4]. Some other diarylheptanoids 
(See Table 1, under supplementary material and Figure 5 and 6) 
besides curcumin showed better binding than curcumin to both 
Histone acetyltransferase and Sarcoendoplasmic Reticulum Ca 
(2+) ATPase enzymes. The table (see Table 1 under Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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supplementary material) shows the binding affinity; inter total 
Energy, intra steric and total energy of the interaction of 
Curcumin and Diarylheptanoids with the HAT and the SERCA 
enzymes. Therefore, a combination of artemisinin and 
diarylheptanoids can prove to be a better combination for 
antimalarial therapy. Diarylheptanoids show better binding to 
curcumin bound SERCA enzyme than to SERCA enzyme 
directly (see Table 3, under supplementary material and Figure 
7) implying that curcumin might be causing some 
conformational change in the SERCA enzyme leading to better 
binding of the diarylheptanoids to the enzymes. Curcumin 
might be having a facilitating effect on the action of 
diarylheptanoids on the SERCA enzyme. Therefore different 
formulations involving curcumin, artimisinin and 
diarylheptanoids may result in a more potent antimalarial drug. 
 
 
Figure 2: Showing hydrogen bond interactions of binding of DAH1 to SERCA enzyme. 
 
 
Figure 3: Showing hydrogen bond interactions of binding of Curcumin to SERCA enzyme. Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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Figure 4: Showing hydrogen bond interactions of binding of DAH1 to Curcumin bound SERCA enzyme 
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Figure 5: Comparative docking energies of Curcumin and diarylheptanoids on HAT Enzyme. 
 
As artemisinin (Figure 1) is active during the intraerythrocyte 
stage of infection and contains an endoperoxide function that is 
essential for its activity, a reasonable hypothesis for the 
mechanism of action of artemisinin is the reductive activation 
of its endoperoxide bridge by Fe (II) heme resulting from the 
digestion of hemoglobin by Plasmodium species. This reaction 
might lead to dioxygen-derived radicals responsible for 
oxidative stress within infected erythrocytes or to C-centered 
radicals OR carbocations that alkylate heme and membrane 
associated parasite proteins e.g. PfTCTP-Plasmodium 
Falciparum translationally controlled tumor protein [5, 6]. An 
important target for artemisinin is Pf ATP6-A SERCA. 
Curcumin belongs to the class of diarylheptanoids i.e. class of 
compounds with two aromatic rings separated by 7 aliphatic 
carbons. Other compounds of this class have substitution of 
different functional groups at different positions. They were 
drawn on CORINA server and their 3D coordinates were 
obtained. They were docked to both Sarcoendoplasmic 
reticulum Ca (2+) ATPase enzyme and Histone 
acetyltransferase enzyme and showed better docking energies 
than Curcumin. Hydrogen bond interactions of 
Diarylheptanoids and Curcumin to the SERCA enzyme have 
been shown in Figure 2 and Figure 3 respectively. 
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Figure 6: Comparative docking energies of curcumin and diarylheptanoids on SERCA Enzyme. 
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Figure 7: Graph showing comparative docking energies of diarylheptanoids when they are docked to SERCA enzyme and to 
curcumin bound SERCA enzyme. 
 
The following compounds which were obtained from the 
pharmacophore based search on Zinc database are the best 
binding compounds on Histone acetyltransferase enzyme 
therefore can be effective inhibitors of the Plasmodium parasite. 
In addition curcumin bound pdb of SERCA enzyme was docked 
with diarylheptanoids. Three of them showed increase in the 
docking energy (see Table 3, supplementary material and 
Figure 7) suggesting that on binding curcumin might be causing 
some conformational change in the enzyme leading to better 
binding of diarylheptanoids. Residues involved in hydrogen 
bond interactions were visualized and compared to those of 
diarylheptanoid bound directly to the SERCA enzyme (see 
supplementary material Table 4; Figure 2 and Figure 4).  
 
On docking Curcumin is showing good binding to both Histone 
acetyltransferase and Sarcoendoplasmic reticulum Ca (2+) 
ATPase enzymes suggesting that its mechanism of action might 
be involving more than one molecular target in the Plasmodium 
parasite. Curcumin might be acting synergistically with 
artemisinin (which forms covalent adducts with the 
transmembrane proteins of the malarial parasite) to inhibit the 
SERCA enzyme, hence potentiating its action. Certain other 
diarylheptanoids show even better binding to the HAT and 
SERCA enzymes (see Figure 5 and Figure 6) and hence might 
make a more effective combination with artemisinin than 
curcumin in inhibiting the malarial parasite. Artemisinin is 
known to be acting by a pathway, which is independent to 
curcumin, therefore diarylheptanoids may be better substitutes 
for curcumin. However, our results have shown that curcumin 
may potentiate the action of diarylheptanoids in enhancing the 
activity of artimisinin. Also there are a group of compounds 
from the Zinc Database search which show good binding 
affinities with the Histone Acetyltransferase enzyme (see Table 
2, shown under supplementary material) and hence can be 
prospective drugs for combination therapy in malaria. 
Appropriate combinations will have to be worked out for 
optimum results. 
 
Conclusion: 
However since the diarylheptanoids are showing better binding 
to both Histone acetyltransferase enzyme and Sarcoendoplasmic 
reticulum Ca (2+) ATPase enzyme, hence they might be better 
inhibitors of both the key enzymes in the Plasmodium parasite, 
therefore it might be possible that a combination of Artemisinin 
and diarylheptanoids can be an even better combination for 
antimalarial therapy. Also, since diarylheptanoids are showing 
better binding to curcumin bound SERCA enzyme than the 
curcumin unbound enzyme, curcumin might be causing some Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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conformational change in the SERCA enzyme leading to better 
binding of the Diarylheptanoids.Therefore different 
formulations involving curcumin, artemisinin and 
diarylheptanoids can be a very effective combination for 
antimalarial therapy. 
 
Author’s contribution: 
Artimisinin and curcumin mixed formulation is known to be an 
effective inhibitor of plasmodium parasite, however the present 
study shows that substitution of curcumin with some 
diarylheptanoids may prove to be a better combination. 
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Supplementary material 
 
Binding energies 
 
S. NO  Structure  Chemical formula 
HAT 
Enzyme 
SERCA 
Enzyme 
1 
 
DAH1 - 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-methoxyphenyl)-1,4,6-heptatrien-3-
one 
 
(i)  -29.18 
(ii)  -164.279 
(iii) 19.2593 
(iv)  -144.562 
(i)  -30.2461 
(ii)  -106.192 
(iii) 17.5476 
(iv)  -88.1829 
2 
 
DAH2 - 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-phenyl-1,4,6-heptatrien-3-one 
 
(i)  -26.2266 
(ii)  -158.909 
(iii) 14.3788 
(iv)  -144.468 
(i)  -25.6674 
(ii)  -93.8525 
(iii) 5.5588 
(iv)  -88.0193 
3 
 
DAH3 - 5-hydroxy-1,7-di(4-hydroxyphenyl)-1,4,6-heptatrien-3-one 
 
(i)  -24.7644 
(ii)  -157.339 
(iii) 10.5144 
(iv)  -146.824 
(i)  -22.4891 
(ii)  -94.5298 
(iii) 1.3044 
(iv)  -93.2254 
4 
 
DAH4 - 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1,4,6-heptatrien-3-one 
 
(i)  -26.5945 
(ii)  -161.974 
(iii) 15.9454 
(iv)  -145.986 
 
(i)  -29.1099 
(ii)  -98.3877 
(iii) 0.068099 
(iv)  -98.4211 
5 
 
CURCUMIN - 1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione  (i)  -17.0122 
(ii)  -166.369 
(iii) 10.8862 
(iv)  -112.07 
(i)  -20.03916 
(ii)  -108.678 
(iii) 12.3604 
(iv)  -81.7927 Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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S.No Energy  total  Compound 
1 -182.4  5388781 
2 -182  5317600 
3 -181  167551 
4 -170  528158 
5 -161  5318148 
6 -146  ZINC  02243778 
7 -141  ZINC  05023674 
8 -135  ZINC  1045599 
9 -133  ZINC  057722412 
10 -112  Curcumin 
Table 2: The results of top 10 best docking compounds on Histone acetyltransferase enzyme 
 
S.No Compound  E.  Tot  (Curcumin 
unbound) 
E. Tot (Curcumin 
bound) 
1 DAH1  -88.182  -88.36 
2 DAH2  -88.01  -97.05 
3 DAH3  -93.22  -99.08 
4 DAH4  -98.42  -107.66 
Table 3: Showing comparative docking energies of diarylheptanoids when they are docked to SERCA enzyme and to curcumin 
bound SERCA enzyme 
 
S No.  Compound  SERCA enzyme  Curcumin bound 
SERCA enzyme 
1 DAH1  Ser610 
Asn330 
Ile931 
Arg325 
2 DAH2  Arg325  Ser610 
3 DAH3  Arg325 
Trp932 
Ser610 
Trp932 
4 DAH4  Arg325 
Trp932 
Ser610 
Table 4: Showing residues forming hydrogen bond interactions at the active site. 
 
 